mitral_valve_repair_supraventricular_tachycardia_maze_procedure
SurgiFrost is used to treat atrial fibrillation during mitral valve
repair. Surgeons use the system during a well-established procedure
(the Maze procedure) that is safe and effective. The use of the Maze
procedure adds just a little more time to the operation. Treating
atrial fibrillation in this manner has a positive impact on the
patient’s lifestyle and reduces the potential for stroke. It also
reduces the patient’s need for anti-arrhythmic and anti-coagulant
medications as well as the side effects associated with them.
Routinely used in more than 125 surgical centers around the world, the
SurgiFrost system uses a malleable, single-use surgical cryoprobe to
treat cardiac arrhythmias while a patient is undergoing a primary
cardiac surgical procedure such as coronary artery bypass grafting
(CABG) or mitral valve (MV) repair and/or replacement. CryoCath
estimates that there are more than 375,000 patients annually worldwide
who are candidates for a combined arrhythmia ablation with the CABG or
MV procedure. SurgiFrost may ultimately be used on a primary basis for
certain surgical procedures such as the stand-alone treatment of AF.
|mitral valve repair|coronary artery bypass|cryosurgery|atrial fibrillation|
| 